Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
Open-market buys, last 90 days
$1,681,140
in 2 filings
Open-market sales, last 90 days
$425,829
in 1 filing, $426K under 10b5-1 plans

Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-15 Kelly Thomas Patrick Chief Financial Officer Option exercise +7,500 22,500
2026-10-15 Kelly Thomas Patrick Chief Financial Officer Option exercise · Restricted Share Units −7,500 22,500
2026-09-30 Kelly Thomas Patrick Chief Financial Officer Purchase +15,000 $37.32 $560K 15,000
2025-10-15 Kelly Thomas Patrick Chief Financial Officer Grant or award · Share Option (Right to Buy) +225,000 225,000
2025-10-15 Kelly Thomas Patrick Chief Financial Officer Grant or award · Restricted Share Units +30,000 30,000

Page 1 of 1 · 5 trades